|
National Stock Number(NSN): 6505-00-616-7878 (6505006167878, 006167878)
| NIIN: |
00-616-7878 |
Item Name: |
DOCUSATE SODIUM CAPSULES |
INC: |
34179
|
| FSC: |
6505
|
Assignment Date: |
Jan-01-1963 |
CRIT: |
X |
IIG: |
34179 |
| ISC: |
5 |
Date Standardized: |
Feb-01-1975 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Aug-31-2022 |
PMIC: |
U |
FIIG: |
A510U0 |
| ESD: |
|
Schedule B: |
3004.90.9250 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
1 |
Originator: |
98 |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
C0LACE |
29398
|
MEAD JOHNSON & COMPANY, LLC |
H |
3 |
1 |
4 |
75 |
|
|
|
|
|
|
|
D0XINATE |
04500
|
HOECHST-ROUSSEL PHARMACEUTICALS INC |
H |
5 |
9 |
4 |
75 |
3 |
B |
|
|
|
|
|
DI0SUCCIN |
21016
|
CONSOLIDATED MIDLAND CORP |
H |
5 |
1 |
4 |
75 |
3 |
D |
|
|
|
|
|
M0L0FAC |
78473
|
SQUIBB E R AND SONS INC WORLD HQ |
H |
5 |
9 |
4 |
75 |
3 |
B |
|
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
100.000 MILLIGRAMS DOCUSATE SODIUM ACTIVE INGREDIENT |
| AKJC |
CAPSULE TYPE |
SOFT |
| CQCT |
PRIMARY CONTAINER TYPE |
BOTTLE |
| CQLS |
CAPSULE CONTENT FORM |
POWDER |
| CYLZ |
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY |
30.000 |
| MDES |
MEDICAL DESIGNATION AND GRADE |
UNITED STATES PHARMACOPEIA |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| G57V |
|
Apr-01-1991 |
0 |
0 |
|
|
54 |
54|57 |
|